intismeran autogene
ProductPersonalized mRNA neoantigen cancer vaccine developed by Moderna and Merck, also known as mRNA-4157 or V940
1 story
Personalized mRNA neoantigen cancer vaccine developed by Moderna and Merck, also known as mRNA-4157 or V940
1 story